A Comprehensive Assessment of Heart Failure in an Elderly Patient

QUESTION

A 65-year-old white woman, Megan Hamilton, presents to the emergency department with orthopnea and paroxysmal nocturnal dyspnea in recent days; worsening dyspnea on exertion for the past few months and now dyspnea at rest; pedal edema; and with a history of dyslipidemia, type II diabetes mellitus, hypertension, coronary artery disease (status post 3-vessel bypass surgery two years ago). She denies any chest pain on exertion or at rest. She reports a history of osteoarthritis.

• Intolerant to ACE inhibitors due to a cough
• No known drug allergies
• Nonsmoker
• Nonalcoholic
• Heart rate: 105 BPM
• Respiratory rate: 22 breaths per minute
• Blood pressure: 130/80
• Room air oxygen saturation on pulse oximetry: 90%
• Amlodipine 2.5 mg each morning
• Losartan 100 mg each morning
• Enteric-coated aspirin 81 mg daily
• Rosuvastatin 20 mg each day
• Metformin 1 gram twice a day
• Ibuprofen 600 mg three times a day
• BMI: 25
• Lungs: Diffuse crackles
• Heart: +S1, +S2 with regular rate and rhythm. No audible murmur. No extra heart sounds auscultated.
• Neck: Elevated jugular venous pressure
• Extremities: 2+ pitting edema
• Echocardiogram: Ejection fraction of 34%
• Chest x-ray: Diffuse vascular congestion. No pleural effusion.
• Electrocardiogram: Sinus tachycardia without evidence of acute ischemia; positive for left ventricular hypertrophy changes
• B-type natriuretic peptide level: Significantly elevated
• Troponin: Normal
• TSH: Normal
• Comprehensive metabolic profile: Normal values except for a non-fasting blood sugar of 250 mg/dl
• CBC: Normal
• Lipids: HDL cholesterol (HDL-C) 30 mg/dl; LDL cholesterol (LDL-C) 120 mg/dl; triglycerides (non-fasting) 400 mg/dl
• Hemoglobin A1C: 9.1 percent

ANSWER

A Comprehensive Assessment of Heart Failure in an Elderly Patient

Introduction

This essay presents a case study of Megan Hamilton, a 65-year-old woman with a complex medical history, who presents to the emergency department with symptoms suggestive of heart failure. This case study aims to provide a comprehensive assessment of the patient’s condition, taking into account her medical history, physical examination findings, and diagnostic test results. The focus will be on evaluating the factors contributing to heart failure and the management of her multiple comorbidities, including dyslipidemia, type II diabetes mellitus, hypertension, and coronary artery disease.

Clinical Presentation

Megan Hamilton presents with symptoms of heart failure, including orthopnea, paroxysmal nocturnal dyspnea, worsening dyspnea on exertion, and pedal edema. Her medical history includes dyslipidemia, type II diabetes mellitus, hypertension, and a history of coronary artery disease with a previous 3-vessel bypass surgery. Physical examination reveals elevated jugular venous pressure, diffuse crackles in the lungs, and 2+ pitting edema in the extremities. Diagnostic tests, including echocardiogram, chest x-ray, and B-type natriuretic peptide level, confirm the diagnosis of heart failure with a reduced ejection fraction of 34%.

Management

Given the complex nature of Megan’s medical history and her newly diagnosed heart failure, a multidisciplinary approach to management is essential. The primary goals of treatment are to improve her symptoms, optimize cardiac function, and reduce the risk of cardiovascular events. The management plan will include the following interventions:

Medication Management: Adjust her current medications, considering her intolerance to ACE inhibitors, to optimize heart failure management. Diuretics, such as furosemide, can be prescribed to relieve edema and improve dyspnea. Beta-blockers, like carvedilol, are indicated to improve cardiac function and reduce heart rate.

Lifestyle Modifications: Encourage lifestyle changes, such as a heart-healthy diet, regular exercise, and smoking cessation, to improve overall cardiovascular health and glycemic control.

Glycemic Control: Optimize glycemic control through medication adjustments, dietary modifications, and close monitoring of blood glucose levels. The high hemoglobin A1C of 9.1% indicates poor diabetes management and highlights the importance of addressing this issue.

Lipid Management: Address dyslipidemia with statin therapy to lower LDL cholesterol levels and reduce the risk of cardiovascular events.

Conclusion

In conclusion, Megan Hamilton’s case highlights the importance of a comprehensive assessment in managing heart failure and its coexisting comorbidities. The management plan should involve a multidisciplinary team approach, focusing on optimizing cardiac function, addressing risk factors, and improving overall cardiovascular health. By addressing Megan’s heart failure and its underlying causes, healthcare providers can enhance her quality of life, reduce the risk of future cardiovascular events, and promote better overall health outcomes.